Differential regulation of hippocampal BDNF mRNA by typical and atypical antipsychotic administration

Brain Research

Volumn 954, Issue 1, 2002, Pages 11-20

  Chlan Fourney, Jennifer ^a   Ashe, Paula ^a   Nylen, Kirk ^a   Juorio, Augusto V ^a   Li, Xin Min ^a  

^a UNIVERSITY OF SASKATCHEWAN   (Canada)

Author keywords

Antipsychotics; BDNF; Hippocampus; mRNA; Neuroleptics; Schizophrenia

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; CLOZAPINE; DOPAMINE 2 RECEPTOR; HALOPERIDOL; MESSENGER RNA; NEUROLEPTIC AGENT; RISPERIDONE; RITANSERIN; SEROTONIN ANTAGONIST;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG MEGADOSE; HIPPOCAMPUS; MALE; NONHUMAN; PRIORITY JOURNAL; PSYCHOSIS; RAT; REGULATORY MECHANISM;

ANIMALS; ANTIPSYCHOTIC AGENTS; BLOTTING, NORTHERN; BRAIN-DERIVED NEUROTROPHIC FACTOR; CLOZAPINE; DOSE-RESPONSE RELATIONSHIP, DRUG; DOWN-REGULATION; GENE EXPRESSION REGULATION; HALOPERIDOL; HIPPOCAMPUS; IN SITU HYBRIDIZATION; MALE; RATS; RATS, WISTAR; RECEPTORS, DOPAMINE D2; REMOXIPRIDE; RISPERIDONE; RITANSERIN; RNA, MESSENGER; TIME FACTORS;

EID: 0036839413     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(02)03215-8     Document Type: Article

References (70)

1. Aloe L., Iannitelli A., Angelucci F., Bersani G., Fiore M. Studies in animal models and humans suggesting a role of nerve growth factor in schizophrenia-like disorders. Behav. Pharmacol. 11:2000;235-242.
2. Andreasen N.C. Positive and negative symptoms of schizophrenia. Acta Psychiatr. Scand. 90:1994;51-59.
3. Angelucci F., Mathe A.A., Aloe L. Brain-derived neurotrophic factor and tyrosine kinase receptor TrkB in rat brain are significantly altered after haloperidol and risperidone administration. J. Neurosci. Res. 60:2000;783-794.
4. Atkins J.B., Chlan-Fourney J., Nye H.E., Hiroi N., Carlezon W.A. Jr., Nestler E.J. Region-specific induction of deltaFosB by repeated administration of typical versus atypical antipsychotic drugs. Synapse. 33:1999;118-128.
5. Barde Y.A. Trophic factors and neuronal survival. Neuron. 2:1989;1525-1534.
6. Beck T., Lindholm D., Castren E., Wree A. Brain-derived neurotrophic factor protects against ischemic cell damage in rat hippocampus. J. Cereb. Blood Flow Metab. 14:1994;689-692.
7. Benes F.M., Davidson J., Bird E.D. Quantitative cytoarchitectural studies of the cerebral cortex of schizophrenics. Arch. Gen. Psychiatry. 43:1986;31-35.
8. Brouha A.K., Shannon-Weickert C., Hyde T.M., Herman M.M., Murray A.M., Bigelow L.B., Weinberger D.R., Kleinman J.E. Reductions in BDNF mRNA in the hippocampus of patients with schizophrenia. Soc. Neurosci. Abstr. 22:1996;1680.
9. Buckland P.R., O'Donovan M.C., McGuffin P. Changes in dopa decarboxylase mRNA but not tyrosine hydroxylase mRNA levels in rat brain following antipsychotic treatment. Psychopharmacology. 108:1992;98-102.
10. Chlan-Fourney J., Li X.M., Juorio A.V., Ashe P., Boulton A.A. Differential regulation of brain derived neurotrophic (BDNF) mRNA in rat brain by chronic haloperidol, risperidone, and clozapine treatment. Soc. Neurosci. Abstr. 24:1998;754.
11. Coyle J.T. The glutamatergic dysfunction hypothesis for schizophrenia. Harv. Rev. Psychiatry. 3:1996;241-253.
12. Dawson N.M., Hamid E.H., Egan M.F., Meredith G.E. Changes in the pattern of brain-derived neurotrophic factor immunoreactivity in the rat brain after acute and subchronic haloperidol treatment. Synapse. 39:2001;70-81.
13. DeLisi L.E. Is schizophrenia a lifetime disorder of brain plasticity, growth, and aging? Schizophr. Res. 23:1997;119-129.
14. Dugich-Djordjevic M.M., Tocco G., Lapchak P.A., Pasinetti G.M., Najm I., Baudry M., Hefti F. Regionally specific and rapid increases in brain-derived neurotrophic factor messenger RNA in the adult rat brain following seizures induced by systemic administration of kainic acid. Neuroscience. 47:1992;303-315.
15. Duinkerk S.J., Botter P.A., Jansen A.A., van Dongen P.A., van Haaften A.J., Boom A.J., van Laarhoven J.H., Busard H.L. Ritanserin, a selective 5-HT2/1C antagonist, and negative symptoms in schizophrenia. A placebo-controlled double-blind trial. Br. J. Psychiatry. 163:1993;451-455.
16. Duman R.S., Heninger G.R., Nestler E.J. Molecular psychiatry. Adaptations of receptor-coupled signal transduction pathways underlying stress- and drug-induced neural plasticity. J. Nerv. Ment. Dis. 182:1994;692-700.
17. Duncan G.E., Sheitman B.B., Lieberman J.A. An integrated view of pathophysiological models of schizophrenia. Brain Res. Brain Res. Rev. 29:1999;250-264.
18. Durany N., Michel T., Zochling R., Boissl K.W., Cruz-Sanchez F.F., Riederer P., Thome J. Brain-derived neurotrophic factor and neurotrophin 3 in schizophrenic psychoses. Schizophr. Res. 52:2001;79-86.
19. Egan M.F., Goldberg T.E., Kolachana B.S., Callicott J.H., Goldman D., Weinberger D.R. Effect of BDNF met66val genotype on verbal memory and risk for schizophrenia. Soc. Neurosci. Abstr. 27:2001;110.23.
20. Falkai P., Bogerts B. Cell loss in the hippocampus of schizophrenics. Eur. Arch. Psychiatry Neurol. Sci. 236:1986;154-161.
21. Feinberg A.P., Vogelstein B. A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity. Anal. Biochem. 132:1983;6-13.
22. Freedman R., Stromberg I., Nordstrom A.L., Seiger A., Olson L., Bygdeman M., Wiesel F.A., Granholm A.C., Hoffer B.J. Neuronal development in embryonic brain tissue derived from schizophrenic women and grafted to animal hosts. Schizophr. Res. 13:1994;259-270.
23. Friston K.J., Frith C.D. Schizophrenia: a disconnection syndrome? Clin. Neurosci. 3:1995;89-97.
24. Horn A.S., Cuello A.C., Miller R.J. Dopamine in the mesolimbic system of the rat brain: endogenous levels and the effects of drugs on the uptake mechanism and stimulation of adenylate cyclase activity. J. Neurochem. 22:1974;265-270.
25. Hughes P., Beilharz E., Gluckman P., Dragunow M. Brain-derived neurotrophic factor is induced as an early immediate gene following N-methyl-D-aspartate receptor activation. Neuroscience. 57:1993;319-328.
26. Hyman C., Hofer M., Barde Y.A., Juhasz M., Yancopoulos G.D., Squinto S.P., Lindsay R.M. BDNF is a neurotrophic factor for dopaminergic neurons of the substantia nigra. Nature. 350:1991;230-232.
27. Hyman S.E., Nestler E.J. The Molecular Foundations of Psychiatry. 1993;American Psychiatric Press, Washington, DC.
28. Jarskog L.F., Gilmore J.H., Selinger E.S., Lieberman J.A. Cortical bcl-2 protein expression and apoptotic regulation in schizophrenia. Biol. Psychiatry. 48:2000;641-650.
29. Jonsson E., Brene S., Zhang X.R., Nimgaonkar V.L., Tylec A., Schalling M., Sedvall G. Schizophrenia and neurotrophin-3 alleles. Acta Psychiatr. Scand. 95:1997;414-419.
30. Kiprianova I., Sandkuhler J., Schwab S., Hoyer S., Spranger M. Brain-derived neurotrophic factor improves long-term potentiation and cognitive functions after transient forebrain ischemia in the rat. Exp. Neurol. 159:1999;511-519.
31. Konradi C., Heckers S. Antipsychotic drugs and neuroplasticity: insights into the treatment and neurobiology of schizophrenia. Biol. Psychiatry. 50:2001;729-742.
32. Kovelman J.A., Scheibel A.B. A neurohistological correlate of schizophrenia. Biol. Psychiatry. 19:1984;1601-1621.
33. Krebs M.O., Guillin O., Bourdell M.C., Schwartz J.C., Olie J.P., Poirier M.F., Sokoloff P. Brain derived neurotrophic factor (BDNF) gene variants association with age at onset and therapeutic response in schizophrenia. Mol. Psychiatry. 5:2000;558-562.
34. Li X.M., Chlan-Fourney J., Juorio A.V., Bennett V.L., Shrikhande S., Keegan D.L., Qi J., Boulton A.A. Differential effects of olanzapine on the gene expression of superoxide dismutase and the low affinity nerve growth factor receptor. J. Neurosci. Res. 56:1999;72-75.
35. Linden A.M., Vaisanen J., Lakso M., Nawa H., Wong G., Castren E. Expression of neurotrophins BDNF and NT-3, and their receptors in rat brain after administration of antipsychotic and psychotrophic agents. J. Mol. Neurosci. 14:2000;27-37.
36. Lindholm D., Dechant G., Heisenberg C.P., Thoenen H. Brain-derived neurotrophic factor is a survival factor for cultured rat cerebellar granule neurons and protects them against glutamate-induced neurotoxicity. Eur. J. Neurosci. 5:1993;1455-1464.
37. Lipska B.K., Khaing Z.Z., Weickert C.S., Weinberger D.R. BDNF mRNA expression in rat hippocampus and prefrontal cortex: effects of neonatal ventral hippocampal damage and antipsychotic drugs. Eur. J. Neurosci. 14:2001;135-144.
38. 2+ concentration, and neurotoxicity and increase antioxidant enzyme activities in hippocampal neurons. J. Neurochem. 65:1995;1740-1751.
39. Mattson M.P., Zhang Y., Bose S. Growth factors prevent mitochondrial dysfunction, and cell injury, but not ATP depletion in hippocampal neurons deprived of glucose. Exp. Neurol. 121:1993;1-13.
40. May P.R., Tuma A.H., Yale C., Potepan P., Dixon W.J. Schizophrenia - a follow-up study of results of treatment. Arch. Gen. Psychiatry. 33:1976;481-486.
41. McGlashan T.H. Early detection and intervention in schizophrenia: research. Schizophr. Bull. 22:1996;327-345.
42. McGorry P.D. The nature of schizophrenia: signposts to prevention. Aust. N.Z. J. Psychiatry. 34:(Suppl.):2000;S14-21.
43. Miller J.C. Induction of c-fos mRNA expression in rat striatum by neuroleptic drugs. J. Neurochem. 54:1990;1453-1455.
44. Molteni R., Lipska B.K., Weinberger D.R., Racagni G., Riva M.A. Developmental and stress-related changes of neurotrophic factor gene expression in an animal model of schizophrenia. Mol. Psychiatry. 6:2001;285-292.
45. Nawa H., Takahashi M., Patterson P.H. Cytokine and growth factor involvement in schizophrenia - support for the developmental model. Mol. Psychiatry. 5:2000;594-603.
46. Neeper S.A., Gomez-Pinilla F., Choi J., Cotman C.W. Physical activity increases mRNA for brain-derived neurotrophic factor and nerve growth factor in rat brain. Brain Res. 726:1996;49-56.
47. Nibuya M., Morinobu S., Duman R.S. Regulation of BDNF and trkB mRNA in rat brain by chronic electroconvulsive seizure and antidepressant drug treatments. J. Neurosci. 15:1995;7539-7547.
48. Niemegeers C.J., Awouters F., Janssen P.A. Serotonin antagonism involved in the antipsychotic effect. Confirmation with ritanserine and risperidone. Encephale. 16:1990;147-151.
49. Paxinos G., Watson C. The Rat Brain in Stereotaxic Coordinates. 2nd Edition. 1986;Academic Press, Orlando, Florida.
50. Phillips H.S., Hains J.M., Laramee G.R., Rosenthal A., Winslow J.W. Widespread expression of BNDF but not NT-3 by target areas of basal forebrain cholinergic neurons. Science. 250:1990;290-292.
51. Pickar D. Perspectives on a time-dependent model of neuroleptic action. Schizophr. Bull. 14:1988;255-286.
52. Rzewuska M. Duration of untreated psychosis during first year of illness as a predictor of prognosis in schizophrenia. Eur. Neuropsychopharmacol. 4:1994;393-394.
53. Sasaki T., Dai X.Y., Kuwata S., Fukuda R., Kunugi H., Hattori M., Nanko S. Brain-derived neurotrophic factor gene and schizophrenia in Japanese subjects. Am. J. Med. Genet. 74:1997;443-444.
54. Schotte A., Janssen P.F., Megens A.A., Leysen J.E. Occupancy of central neurotransmitter receptors by risperidone, clozapine and haloperidol, measured ex vivo by quantitative autoradiography. Brain Res. 631:1993;191-202.
55. Seeman P., Lee T., Chau-Wong M., Wong K. Antipsychotic drug doses and neuroleptic/dopamine receptors. Nature. 261:1976;717-719.
56. Selemon L.D., Rajkowska G.R., Goldman-Rakic P.S. Abnormally high neuronal density in the schizophrenic cortex: a morphometric analysis of prefrontal area 9 and occipital area 17. Arch. Gen. Psychiatry. 52:1995.
57. Singh M., Meyer E.M., Simpkins J.W. The effect of ovariectomy and estradiol replacement on brain-derived neurotrophic factor messenger ribonucleic acid expression in cortical and hippocampal brain regions of female Sprague-Dawley rats. Endocrinology. 136:1995;2320-2324.
58. Smith M.A., Makino S., Kvetnansky R., Post R.M. Stress and glucocorticoids affect the expression of brain-derived neurotrophic factor and NT-3 mRNA in the hippocampus. J. Neurosci. 15:1995;1768-1777.
59. Takahashi M., Shirakawa O., Toyooka K., Kitamura N., Hashimoto T., Maeda K., Koizumi S., Wakabayashi K., Takahashi H., Someya T., Nawa H. Abnormal expression of brain-derived neurotrophic factor and its receptor in the corticolimbic system of schizophrenic patients. Mol. Psychiatry. 5:2000;293-300.
60. Thome J., Foley P., Riederer P. Neurotrophic factors and the maldevelopmental hypothesis of schizophrenic psychoses. J. Neural. Transm. 105:1998;85-100.
61. Vaidya V.A., Marek G.J., Aghajanian G.K., Duman R.S. 5-HT2A receptor-mediated regulation of brain-derived neurotrophic factor mRNA in the hippocampus and the neocortex. J. Neurosci. 17:1997;2785-2795.
62. Vicente A.M., Macciardi F.M.M., Niznik H.B., King N., Bean G., Kennedy J.L. Association between the BDNF gene and schizophrenia. Soc. Neurosci. Abs. 22:1996;96.15.
63. Virgos C., Martorell L., Valero J., Figuera L., Civeira F., Joven J., Labad A., Vilella E. Association study of schizophrenia with polymorphisms at six candidate genes. Schizophr. Res. 49:2001;65-71.
64. Waddington J.L., Scully P.J., Youssef H.A. Developmental trajectory and disease progression in schizophrenia: the conundrum, and insights from a 12 year prospective study in the Monaghan 101. Schizophr. Res. 23:1997;107-118.
65. Weinberger D.R. Implications of normal brain development for the pathogenesis of schizophrenia. Arch. Gen. Psychiatry. 44:1987;660-669.
66. Wiesel F.A., Nordstrom A.L., Farde L., Eriksson B. An open clinical and biochemical study of ritanserin in acute patients with schizophrenia. Psychopharmacology (Berl). 114:1994;31-38.
67. Woods B.T. Is schizophrenia a progressive neurodevelopmental disorder? Toward a unitary pathogenetic mechanism. Am. J. Psychiatry. 155:1998;1661-1670.
68. Wyatt R.J. Early intervention for schizophrenia: can the course of the illness be altered? Biol. Psychiatry. 38:1995;1-3.
69. Xu H., Qing H., Lu W., Keegan D., Richardson J.S., Chlan-Fourney J., Li X.M. Quetiapine attenuates the immobilization stress-induced decrease of brain-derived neurotrophic factor expression in rat hippocampus. Neurosci. Lett. 321:2002;65-68.
70. Yamada K., Mizuno M., Nabeshima T. Role for brain-derived neurotrophic factor in learning and memory. Life Sci. 70:2002;735-744.